Table 2 Adverse events (grades 1 and 2)
Event | Grade 1 | Grade 2 | Total |
|---|---|---|---|
Asthenia | 4 (16%) | 1 (4%) | 5 (20%) |
Headache | 2 (8%) | 1 (4%) | 3 (12%) |
Proteinuria | 2 (8%) | 0 (0%) | 2 (8%) |
Hypertension | 1 (4%) | 1 (4%) | 2 (8%) |
Diarrhea | 2 (8%) | 0 (0%) | 2 (8%) |
Pruritus | 0 (0%) | 1 (4%) | 1 (4%) |
Hyporexia | 0 (0%) | 1 (4%) | 1 (4%) |
Nausea | 0 (0%) | 1 (4%) | 1 (4%) |
Pneumonitis | 0 (0%) | 1 (4%) | 1 (4%) |
Thrombosis | 0 (0%) | 1 (4%) | 1 (4%) |
Infection | 0 (0%) | 1 (4%) | 1 (4%) |
Elevated amylase | 1 (4%) | 0 (0%) | 1 (4%) |
Elevated lipase | 1 (4%) | 0 (0%) | 1 (4%) |
Rash | 1 (4%) | 0 (0%) | 1 (4%) |
Xerosis | 1 (4%) | 0 (0%) | 1 (4%) |
Hypothyroidism | 1 (4%) | 0 (0%) | 1 (4%) |
Abdominal pain | 1 (4%) | 0 (0%) | 1 (4%) |
Vomiting | 1 (4%) | 0 (0%) | 1 (4%) |
Pyrexia | 1 (4%) | 0 (0%) | 1 (4%) |
Arthralgia | 1 (4%) | 0 (0%) | 1 (4%) |
Xerophtalmia | 1 (4%) | 0 (0%) | 1 (4%) |